KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Best Buy (BBY) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Best Buy (BBY) over the last 17 years, with Q4 2025 value amounting to $923.0 million.

  • Best Buy's Cash & Equivalents rose 4354.59% to $923.0 million in Q4 2025 from the same period last year, while for Nov 2025 it was $923.0 million, marking a year-over-year increase of 4354.59%. This contributed to the annual value of $1.6 billion for FY2025, which is 905.32% up from last year.
  • According to the latest figures from Q4 2025, Best Buy's Cash & Equivalents is $923.0 million, which was up 4354.59% from $1.5 billion recorded in Q3 2025.
  • Over the past 5 years, Best Buy's Cash & Equivalents peaked at $5.5 billion during Q1 2021, and registered a low of $636.0 million during Q4 2023.
  • For the 5-year period, Best Buy's Cash & Equivalents averaged around $1.9 billion, with its median value being $1.3 billion (2024).
  • In the last 5 years, Best Buy's Cash & Equivalents skyrocketed by 14647.82% in 2021 and then tumbled by 8503.97% in 2022.
  • Over the past 5 years, Best Buy's Cash & Equivalents (Quarter) stood at $3.5 billion in 2021, then tumbled by 73.1% to $932.0 million in 2022, then tumbled by 31.76% to $636.0 million in 2023, then grew by 1.1% to $643.0 million in 2024, then soared by 43.55% to $923.0 million in 2025.
  • Its Cash & Equivalents stands at $923.0 million for Q4 2025, versus $1.5 billion for Q3 2025 and $1.1 billion for Q2 2025.